8-bromo cyclic adenosine monophosphate and Fetal Growth Restriction

8-bromo cyclic adenosine monophosphate has been researched along with Fetal Growth Restriction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aharon, A; Al-Dabet, MM; Brenner, B; Fahlbusch, FB; Gadi, I; Hoffmann, J; Huebner, H; Isermann, B; Kohli, S; Lochmann, F; Löttge, M; Manoharan, J; Markmeyer, P; Ruebner, M; Shahzad, K; Zenclussen, AC1

Other Studies

1 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Fetal Growth Restriction

ArticleYear
p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restriction.
    Cell death & disease, 2017, 04-06, Volume: 8, Issue:4

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylation; Animals; Apoptosis; Caspase 3; Cell Differentiation; DNA-Binding Proteins; Female; Fetal Growth Retardation; Humans; Mice; NF-E2 Transcription Factor, p45 Subunit; Nuclear Proteins; Pregnancy; Protein Processing, Post-Translational; Sumoylation; Transcription Factors; Trophoblasts

2017